News
Gilead Sciences chairman and CEO Daniel O’Day joins 'Squawk Box' to discuss the FDA approval of the company's HIV prevention ...
StockStory.org on MSN13h
5 Insightful Analyst Questions From Gilead Sciences’s Q1 Earnings CallGilead Sciences’ first quarter performance saw sales remain flat year over year, which did not meet Wall Street’s revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback